[

johnson and johnson

]
PAGE 2

J&J seeks permission for phase-3 trial of its Covid-19 vaccine in India

This comes close to the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization.
Johnson & Johnson's vaccine is a single-dose jab, whereas the three vaccines cleared by India so far are of doubles doses.(Reuters file photo)
Johnson & Johnson's vaccine is a single-dose jab, whereas the three vaccines cleared by India so far are of doubles doses.(Reuters file photo)
Published on Apr 19, 2021 11:15 PM IST
Copy Link
PTI | , New Delhi

EU Commission to not renew AstraZeneca, Johnson & Johnson vaccine contracts

A report said that Brussels would rather focus on Covid-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer's and Moderna's.
Covid-19 vaccines of AstraZeneca and Johnson & Johnson.(Bloomberg)
Covid-19 vaccines of AstraZeneca and Johnson & Johnson.(Bloomberg)
Published on Apr 14, 2021 04:48 PM IST
Copy Link
Reuters |

Nations mull pause on Johnson & Johnson Covid-19 vaccine over blood clot reports

Concerns similar to those regarding Johnson & Johnson Covid-19 vaccine were also raised for AstraZeneca Plc Covid-19 shot after three people, who took the vaccine, were hospitalised in Norway with complaints of blood clots.
US health agencies said they were investigating unusual clots in patients who've received the Johnson & Johnson vaccine.(Reuters File Photo )
US health agencies said they were investigating unusual clots in patients who've received the Johnson & Johnson vaccine.(Reuters File Photo )
Published on Apr 14, 2021 01:17 PM IST
Copy Link
Byhindustantimes.com | Edited by Kanishka Sarkar, Hindustan Times, New Delhi

Australia rules out adding J&J Covid-19 vaccine to inoculation plan

The government had been in talks with Johnson and Johnson, which had asked the Australian regulator, Therapeutic Goods Administration, for provisional registration.
FILE PHOTO: Vials with a sticker reading,
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo(REUTERS)
Published on Apr 13, 2021 04:09 PM IST
Copy Link
PTI | | Posted by Srivatsan K C, Canberra

Johnson & Johnson in discussion with India to start Janssen's clinical trails

"We are in discussions with the Government of India with the objective of starting a bridging clinical study of our Janssen Covid-19 vaccine candidate in India, subject to local regulatory approvals," a company statement said.
Janssen vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.(Bloomberg)
Janssen vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.(Bloomberg)
Published on Apr 09, 2021 07:18 PM IST
Copy Link
ANI | , New Delhi

How does the J&J Covid-19 vaccine authorization affect US' Covid-19 drive?

The trials had important differences, making comparison difficult. Pfizer and Moderna focused on efficacy against mild-to-moderate sickness, while J&J's trial looked for efficacy against moderate-to-severe COVID-19.
J&J said it expects to ship nearly 4 million doses in the first week, and shipments could begin late Sunday or early Monday.(Reuters)
J&J said it expects to ship nearly 4 million doses in the first week, and shipments could begin late Sunday or early Monday.(Reuters)
Updated on Feb 28, 2021 11:20 AM IST
Copy Link
Reuters | , Washington

J&J Covid-19 vaccine receives emergency approval in US

  • The committee's 22 members were convened by the Food and Drug Administration and included leading scientists as well as consumer and industry representatives.
An emergency use authorization (EUA) will likely follow, probably in the coming days, making the J&J vaccine the third to be greenlighted in the United States after Pfizer's and Moderna's were provisionally approved in December.(MINT_PRINT)
An emergency use authorization (EUA) will likely follow, probably in the coming days, making the J&J vaccine the third to be greenlighted in the United States after Pfizer's and Moderna's were provisionally approved in December.(MINT_PRINT)
Published on Feb 27, 2021 05:29 AM IST
Copy Link
AFP | , Washington

FDA advisory panel to review J&J Covid-19 vaccine with thumbs up expected

After it receives the recommendation, the FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires just one shot.
In a 44,000-person trial, the vaccine overall was 66% effective at preventing moderate-to-severe cases of Covid-19 compared with a placebo.(AP)
In a 44,000-person trial, the vaccine overall was 66% effective at preventing moderate-to-severe cases of Covid-19 compared with a placebo.(AP)
Published on Feb 26, 2021 11:09 PM IST
Copy Link
Reuters |

South Africa readies for J&J Covid-19 vaccine inoculation to health care workers

The first batch of 80,000 doses of the J&J vaccine, which has not been authorised for general use in South Africa, is expected to arrive imminently and will be given to health care professionals across the country, health minister Zweli Mkhize told parliament.
“We salute the health care workers who have chosen vaccination for their own protection and the protection of their colleagues, families and community members,
“We salute the health care workers who have chosen vaccination for their own protection and the protection of their colleagues, families and community members," Mkhize said(Reuters)
Published on Feb 17, 2021 12:50 PM IST
Copy Link
PTI | , Johannesburg

South Africa plans to accelerate supply of J&J, Pfizer shots

The South African arm of the trial found that the shot from Astra and the University of Oxford had only 22% efficacy against mild and moderate illness, according to lead researcher Shabir Madhi on Sunday.
The unrelenting pressure on the world’s vaccine supplies might only lift when more shots prove successful, said Krishna Udayakumar, director of the Duke Global Health Institute.(AFP)
The unrelenting pressure on the world’s vaccine supplies might only lift when more shots prove successful, said Krishna Udayakumar, director of the Duke Global Health Institute.(AFP)
Updated on Feb 08, 2021 04:08 PM IST
Copy Link
Bloomberg |

Covid-19 vaccine update: Pfizer applies for EUA in Japan, FDA to approve Moderna candidate

Oxford University said on Thursday its candidate has shown better immune response when a two full-dose regime is given, rather than a full-dose followed by a half-dose booster.
Pfizer has developed its vaccine candidate with BioNTech SE (FILE PHOTO)
Pfizer has developed its vaccine candidate with BioNTech SE (FILE PHOTO)
Updated on Dec 18, 2020 10:05 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Johnson & Johnson ordered to pay $120 million damages in New York baby powder case

Justice Gerald Lebovits of the state supreme court in Manhattan reduced the payout from the $325 million a jury awarded Donna Olson, 67, and Robert Olson, 65, in May 2019 following a 14-week trial.
Johnson & Johnson said it will appeal the verdict, citing “significant legal and evidentiary errors” at the trial.(Reuters)
Johnson & Johnson said it will appeal the verdict, citing “significant legal and evidentiary errors” at the trial.(Reuters)
Updated on Nov 21, 2020 06:25 AM IST
Copy Link
New York | ByReuters | Posted by Prashasti Singh

Covid-19 vaccine update: Pfizer announces 95% efficacy, Spain authorises phase 3 trial of Janssen’s candidate

Officials in the United States have said freezers required to store Covid-19 vaccines, once approved, are in place at health facilities that will administer initial doses.
Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020 (REUTERS/Dado Ruvic/Illustration/File Photo)
Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020 (REUTERS/Dado Ruvic/Illustration/File Photo)
Updated on Nov 19, 2020 08:44 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Covid-19 vaccine update: Bharat Biotech begins phase 3 trials, Moderna says its candidate nearly 95% effective

Meanwhile, Johnson and Johnson has launched a second phase 3 trial, besides its existing one. Also, India is reportedly in talks with several firms over their respective coronavirus vaccine candidates with regards to the progress of trials, vaccine efficacy, safety etc.
FILE PHOTO: A man rides his motorcycle past a parked bus of Bharat Biotech outside its office in Hyderabad (REUTERS/Stringer/File Photo)
FILE PHOTO: A man rides his motorcycle past a parked bus of Bharat Biotech outside its office in Hyderabad (REUTERS/Stringer/File Photo)
Updated on Nov 17, 2020 08:57 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

J&J starts two-dose trial of its Covid-19 vaccine candidate in the UK

The UK arm of the study is aiming to recruit 6,000 participants among a total of 30,000 people globally, scientists leading the UK trial said. Volunteers will be recruited at 17 sites across the UK.
J&J signed an agreement for the two-dose global Phase III clinical trial with the British government in August, to run in parallel with a 60,000-person trial of a single shot of the experimental vaccine which was launched in September.(Reuters)
J&J signed an agreement for the two-dose global Phase III clinical trial with the British government in August, to run in parallel with a 60,000-person trial of a single shot of the experimental vaccine which was launched in September.(Reuters)
Updated on Nov 16, 2020 07:33 AM IST
Copy Link
London | ByReuters | Posted by Prashasti Singh

Covid-19 vaccine update: From CureVac candidate’s immune response in humans to unwilling Russians

South Africa’s Aspen Pharmacare has announced a deal with Johnson & Johnson to manufacture its Covid-19 vaccine candidate, once approved. Meanwhile, a survey in Russia shows 59% of Russians are unwilling to be inoculated once a vaccine becomes available.
Representative Image (REUTERS/Kai Pfaffenbach/File Photo)
Representative Image (REUTERS/Kai Pfaffenbach/File Photo)
Updated on Nov 03, 2020 08:32 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Supreme Court closes case against Johnson and Johnson in faulty hip implants case

The PIL had alleged that “faulty” and “deadly” hip implants have been fitted into the bodies of 4,525 Indian patients who had undergone the replacement surgeries since 2005.
The Supreme Court closed the case seeking action against Johnson and Johnson for implanting faulty hip implants into patients, saying that steps have been taken by the Centre to provide compensation of up to Rs 1.22 crore to them.(Sonu Mehta/HT Photo)
The Supreme Court closed the case seeking action against Johnson and Johnson for implanting faulty hip implants into patients, saying that steps have been taken by the Centre to provide compensation of up to Rs 1.22 crore to them.(Sonu Mehta/HT Photo)
Updated on Jan 11, 2019 02:16 PM IST
Copy Link
New Delhi | ByPress Trust of India

Meet Vijay Vojhala, the lone fighter who took on Johnson & Johnson for faulty hip implants

Six months after the hip replacement surgery, Vijay Vojhala -- a medical representative -- said his pain increased and his limp became more pronounced, with the new joints squeaking when he walked.
Vojhala was diagnosed with avascular necrosis, a condition where the bone tissue dies because of the loss of blood supply.(HT Photo)
Vojhala was diagnosed with avascular necrosis, a condition where the bone tissue dies because of the loss of blood supply.(HT Photo)
Updated on Aug 25, 2018 07:16 AM IST
Copy Link
Hindustan Times, New Delhi | ByAnonna Dutt
SHARE
  • 1
  • 2
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, December 06, 2021